Wegovy (semaglutide) Wegovy is a GLP-1 agonist medication that is approved to: Aid in weight loss for adults and children over 12 years old who have obesity, or in adults who have overweight and have a weight-related health condition (such as high blood pressure, type 2 diabetes , or high cholesterol) Reduce the risk of major cardiovascular events, such as heart attack or stroke, in adults who have cardiovascular disease and have obesity or overweight Wegovy comes in a single-use pen that you inject once per week, either with or without food
This often leads to weight gain, fatigue, and a feeling of being "stuck," which is exactly why many people with thyroid issues find themselves considering GLP-1 medications
Frustrated that even GLP-1 medications aren't giving you the results you expected
On a side note, Zoox also announced that by late 2025, it had driven over 1 million autonomous miles, transporting more than 300,000 riders in cities like San Francisco (Explorers program) and Las Vegas